Vascular Immunologic Technologies LLC entered the industry of Biological Research in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Biological Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Biological Research. The business provides service to the B2B market.
To acquire more information, please contact Douglas L Jicha by calling No number given during business hours. You can also write to the business’ Single Location at 808 Olive Glen Court, Santa Rosa, California CA 95404. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Vascular Immunologic Technologies LLC |
| Representative: | Douglas L Jicha |
| Place of Business: | 808 Olive Glen Court, Santa Rosa, CA 95404 |
| Contact Number: | No number given |
| Type of Service: | Biological Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2001 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Vascular Immunologic Technologies LLC is a company operating from Sonoma, California providing professional Biological Research and relevant B2B variables. It was founded in 2001 and registered with the SIC code 8731 as Biological Research, and with the NAICS code 541712 as Biological Research.
With a current employee count of 1 to 4, Vascular Immunologic Technologies LLC has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Douglas L Jicha at No number given for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 808 Olive Glen Court in Santa Rosa, California 95404 and can be engaged online through the company website at , the company Twitter , and Facebook page .